The effect of systemically administrated zoledronic acid on the osseointegration of dental implants
dc.contributor.author | Ayan, M. | |
dc.contributor.author | Dolanmaz, D. | |
dc.contributor.author | Mihmanli, A. | |
dc.contributor.author | Ayan, A. | |
dc.contributor.author | Kurkcu, M. | |
dc.date.accessioned | 2020-03-26T18:31:38Z | |
dc.date.available | 2020-03-26T18:31:38Z | |
dc.date.issued | 2012 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Oral Diseases (2012) 18, 802808 Objective: The aim of conducting this study was to evaluate the effect of zoledronic acid (ZA) on the new bone formation (NBF) after the insertion of a titanium dental implant, which is very popular treatment in dentistry. Study Design: Twelve New Zealand white rabbits were used in this study. The rabbits were divided in two groups. ZA was systemically administered to the study group. Titanium implants were placed to the left and right tibias of the rabbits. Results: The data from the ZA group revealed a statistically significant increase in the bone mineral content and the bone mineral density. A non-decalcified histomorphometric examination conducted on the study group revealed a significant increase of NBF and bone-implant contact (BIC) at 2 and 4 weeks. Conclusion: A single dose of systemic ZA administration increases the rate of NBF and augments the quality of the bone. | en_US |
dc.description.sponsorship | Scientific Research Project Fund of Selcuk UniversitySelcuk University [062020006] | en_US |
dc.description.sponsorship | This study was supported by the Scientific Research Project Fund of Selcuk University under project number 062020006. | en_US |
dc.identifier.doi | 10.1111/j.1601-0825.2012.01948.x | en_US |
dc.identifier.endpage | 808 | en_US |
dc.identifier.issn | 1354-523X | en_US |
dc.identifier.issn | 1601-0825 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 22712806 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 802 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1111/j.1601-0825.2012.01948.x | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/28496 | |
dc.identifier.volume | 18 | en_US |
dc.identifier.wos | WOS:000309186600012 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | WILEY | en_US |
dc.relation.ispartof | ORAL DISEASES | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | dental implant | en_US |
dc.subject | zoledronic acid | en_US |
dc.subject | osseointegration | en_US |
dc.subject | non-decalcified histology | en_US |
dc.title | The effect of systemically administrated zoledronic acid on the osseointegration of dental implants | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 28496.pdf
- Boyut:
- 393.99 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Makale Dosyası